![Alexander DAMANAKIS | PostDoc Position | Doctor of Medicine | Johns Hopkins University, MD | JHU | Department of Pathology | Research profile Alexander DAMANAKIS | PostDoc Position | Doctor of Medicine | Johns Hopkins University, MD | JHU | Department of Pathology | Research profile](https://i1.rgstatic.net/ii/profile.image/1085363808415744-1635782305510_Q512/Alexander-Damanakis-2.jpg)
Alexander DAMANAKIS | PostDoc Position | Doctor of Medicine | Johns Hopkins University, MD | JHU | Department of Pathology | Research profile
![Views of Primary Education Teachers on the Effectiveness of the Use of Experiential Participatory Methods in the Teaching Context of the Hosting Classes Views of Primary Education Teachers on the Effectiveness of the Use of Experiential Participatory Methods in the Teaching Context of the Hosting Classes](https://static.wixstatic.com/media/ed8b62_6a95ff933a4f46909c0dfb6a79cf1097~mv2.png/v1/fill/w_1246,h_964,al_c/iosif.png)
Views of Primary Education Teachers on the Effectiveness of the Use of Experiential Participatory Methods in the Teaching Context of the Hosting Classes
Tissue clearing and 3D reconstruction of digitized, serially sectioned slides provide novel insights into pancreatic cancer
Tissue clearing and 3D reconstruction of digitized, serially sectioned slides provide novel insights into pancreatic cancer
![Alexander DAMANAKIS | PostDoc Position | Doctor of Medicine | Johns Hopkins University, MD | JHU | Department of Pathology | Research profile Alexander DAMANAKIS | PostDoc Position | Doctor of Medicine | Johns Hopkins University, MD | JHU | Department of Pathology | Research profile](https://www.researchgate.net/publication/365943803/figure/fig1/AS:11431281104163492@1669953970328/Immunohistochemistry-staining-for-integrin-beta1-ITGB1-Negative-tumor-sample-for-ITGB1_Q320.jpg)
Alexander DAMANAKIS | PostDoc Position | Doctor of Medicine | Johns Hopkins University, MD | JHU | Department of Pathology | Research profile
![Study protocol of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5-fluorouracil/Folinic acid followed by Study protocol of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5-fluorouracil/Folinic acid followed by](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-021-08966-3/MediaObjects/12885_2021_8966_Fig1_HTML.png)